Advanced Soft-Tissue Sarcoma: Integrating Monoclonal Antibody Therapy

Advanced Soft-Tissue Sarcoma: Integrating Monoclonal Antibody Therapy

Episodes

Specialty:

All

Year:

All

EP. 1: Disease State: Advanced Soft Tissue Sarcoma

November 8th 2016

EP. 2: Multidisciplinary Care of STS

November 8th 2016

EP. 3: FDA Approval of Olaratumab + Doxorubicin for STS

November 8th 2016

EP. 4: Registration Trials for Olaratumab and Doxorubicin for STS

November 8th 2016

EP. 5: Practical Implications of Using Olaratumab in Patients with STS

November 8th 2016

EP. 6: OS vs PFS with Olaratumab

November 8th 2016

EP. 7: Appropriate Patients for Olaratumab + Doxorubicin

November 8th 2016

EP. 8: Sequencing with Olaratumab in STS

November 8th 2016

EP. 9: Toxicity of Olaratumab and Doxorubicin

November 8th 2016

EP. 10: Final Thoughts on STS

November 8th 2016

Trending on OncLive

ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

Dr Wainberg on INCB161734 Activity in Refractory Pancreatic Cancer

European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma

ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer

CAR T-Cell Therapy Continues to Make Its Case in Early Relapsed Myeloma